← FDA Drug Approvals (Drugs@FDA)

PALIPERIDONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2024-09-26

Drug application

FDA Application #

ANDA218330

Application type

Abbreviated New Drug Application (Generic)

Brand name

PALIPERIDONE

Generic name

PALIPERIDONE

Active ingredients

PALIPERIDONE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Limited

First approval

2024-09-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown